Featured Episode
TWiV reviews the results of a phase 3 trial of a self-amplifying mRNA COVID-19 vaccine, and the finding that baseline innate and T cell populations are correlates of protection against symptomatic influenza virus infection independent of serology.
- Beyond the Noise #39: Connecticut stands up for its childrenby profvrr on May 14, 2024 at 12:54 am
Connecticut recently bucked the national trend by eliminating a religious exemption to vaccination. The post Beyond the Noise #39: Connecticut stands up for […]
- Immune 78: Tolerance and tolerating many vaccinesby profvrr on March 26, 2024 at 7:27 pm
Immune discusses responses in a COVID hypervaccinated individual, synthetically glycosylated antigens for the antigen-specific suppression of established […]
- Infectious Disease Puscast #54by profvrr on May 14, 2024 at 5:00 am
On episode #54 of the Infectious Disease Puscast, Daniel and Sara review the infectious disease literature for the weeks of 4/25 – 5/8/24. The post Infectious […]
- Matters Microbial #40: Using THOR’s hammer to investigate microbial communitiesby profvrr on May 16, 2024 at 9:14 pm
Today, Dr. Jo Handelsman of the University of Wisconsin Madison and Director of the Wisconsin Institute for Discovery joins the #QualityQuorum to discuss the […]
- TWiM 309: Stomach acid can be your friendby profvrr on April 26, 2024 at 7:57 pm
On this episode of TWiM, a charcuterie invasion, and how that acid in your stomach may protect from the invading hordes of microbes. The post TWiM 309: Stomach […]